SCHEMBL28201240

SCHEMBL28201240

NC(=O)C(CO)N1CCN(c2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.53
ADRA2B P18089 1/20 0.53
ADRA2C P18825 1/20 0.53
PLAU P00749 1/20 0.51
PLAUR Q03405 1/20 0.51
MAPT P10636 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 1/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 3/20 0.45
MEN1 O00255 1/20 0.45
USP2 O75604 1/20 0.45
TSHR P16473 1/20 0.45
KMT2A Q03164 1/20 0.45
RAD52 P43351 1/20 0.45
TAAR1 Q96RJ0 1/20 0.44
HTT P42858 1/20 0.44
GRM5 P41594 1/20 0.43
HTR1A P08908 1/20 0.43
HTR7 P34969 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6530016 0.86 PLAU (0.50) ADRA2AADRA2BADRA2CPLAUPLAUR
SCHEMBL28201246 0.81 L3MBTL1 (0.52) LMNAALDH1A1MEN1KMT2ATAAR1
SCHEMBL4925039 0.78 MAPT (0.50) ADRA2AADRA2BADRA2CMAPTNPSR1
SCHEMBL28201210 0.76 TSHR (0.58) LMNAPKMALDH1A1MEN1TSHR
SCHEMBL27730027 0.76 RAD52 (0.49) ADRA2AADRA2BADRA2CMAPTNPSR1
SCHEMBL29954675 0.75 USP2 (0.45) ADRA2AADRA2BADRA2CMAPTNPSR1
SCHEMBL6973198 0.75 ADRA2A (0.65) ADRA2AADRA2BADRA2CMAPTNPSR1
SCHEMBL17198006 0.73 ADRA2A (0.58) ADRA2AADRA2BADRA2CMAPTPKM
SCHEMBL7424307 0.72 ADRA2A (0.57) ADRA2AADRA2BADRA2CNPSR1PKM
SCHEMBL844603 0.72 PLAU (0.40) PLAUPLAURLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107735397-A GPR55 receptor active selective modulators:Chromene pyrazole derivatives 高等科学研究委员会(CSIC) 2018-02-23 CN disclosed